Quick Answer
An OCD treatment review is a structured look at a plan that isn't working. It checks the diagnosis, whether medication trials were adequate in dose and length, whether ERP was true exposure therapy done consistently, and what might be blocking progress. Next steps may include switching SSRIs, clomipramine or augmentation.
Understanding OCD Treatment Review
OCD treatment doesn’t always work the first time. Some people try several medications or years of therapy and still spend hours on rituals. When progress stalls, it’s worth stepping back and reviewing the whole plan. A structured review looks at what’s been tried, how it was tried and what might be getting in the way. It’s not about blame. It’s about finding a better path forward. Many people who felt stuck improve after a review leads to a more targeted approach, whether that’s a properly dosed medication trial, real ERP or a well-chosen next step. This guide is part of our New York OCD guide.
The International OCD Foundation reports that with any given SSRI trial, about 40% to 60% of people with OCD have a clinically significant improvement. It also cautions that trials are often deemed failures when the dose wasn’t high enough or the trial wasn’t long enough, noting an adequate trial requires 8 to 12 weeks with at least six weeks at moderate to high doses. A review checks each past trial against that standard. Our guide on measurement-based OCD care explains how scores help judge trials.
For New Yorkers who’ve tried OCD treatment without relief, a structured review can turn frustration into a clear plan. According to the International OCD Foundation, about 1 in 40 U.S. adults currently has OCD. Secure video visits from anywhere in New York can make it easier to start OCD care without adding travel to an already crowded day.
Checking the OCD diagnosis, adequate SSRI trials for OCD, and ERP quality and augmentation are the three parts of a review this guide covers.
Medication next steps
The foundation notes that if an adequate first SSRI trial doesn’t work, the two most common strategies are starting or intensifying ERP and switching to a different SSRI. If one or two SSRI trials fail, next steps include switching to clomipramine, augmenting with a second medication or switching to a second-line option. It describes low-dose antipsychotic augmentation, such as aripiprazole or risperidone, as the most evidence-based augmentation strategy, helping about one-third of people who didn’t respond to an SSRI alone.
Consistency and blockers
The foundation also stresses confirming that medication was taken as prescribed, at the right dose and intervals. Other blockers include heavy alcohol or cannabis use, benzodiazepines that blunt exposure learning, family accommodation, severe sleep problems and ongoing stress. Addressing these can unlock progress.
OCD Treatment Review at a glance
| Question | Why it matters |
|---|---|
| Is it OCD, and only OCD? | Other conditions can mimic or add to OCD |
| Were SSRI trials adequate? | Dose and time both count |
| Was ERP true ERP? | Talk therapy isn’t the same |
| Was medication taken consistently? | Missed doses reduce benefit |
| What's next? | Switch, clomipramine or augmentation |
Checking the OCD diagnosis
Sometimes treatment stalls because the picture is more complicated. Depression, bipolar disorder, ADHD, autism, tic disorders, body-focused repetitive behaviors, eating disorders, PTSD or substance use can overlap with OCD and change what’s needed. Poor insight can make ERP harder to engage in. A careful re-evaluation, often with the Y-BOCS, can clarify. The foundation also recommends checking for other psychiatric or physical conditions that could explain a lack of response.
Was it really ERP?
Many people have had therapy that didn’t target OCD directly, like general talk therapy or reassurance-based approaches. True ERP involves a structured hierarchy of exposures and deliberate resistance of rituals, practiced regularly between sessions. The foundation describes ERP as the first-line therapy for OCD. If ERP hasn’t been tried properly, or was stopped early, starting or intensifying it is often the most powerful next step. Our guides on measurement-based OCD care and N-acetylcysteine for OCD cover related topics.
OCD treatment reviews for New York patients
OCD treatment reviews work well by secure video, with records and scores reviewed together. Visits run by secure video anywhere in New York, while you’re physically in the state. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office, and see self-pay fees on the Good Faith Estimate page.
Setting clear goals
A review is a chance to reset goals. What matters most right now: fewer hours on rituals, getting to work on time, touching things you’ve avoided? Clear goals help choose the next step and measure progress with the Y-BOCS alongside daily life changes.
When to ask for a review
Ask for a review if you’ve been in treatment for several months without meaningful improvement, have tried several medications without success, or feel stuck. A second opinion is also reasonable. Thoughts of self-harm need immediate help through 988 or 911. Stalled OCD treatment is common, and many people improve after the plan is reassessed.
Key Takeaways
- Stalled progress is a signal to review the plan, not to give up.
- The IOCDF notes SSRI trials are often judged too early or at too low a dose.
- About 40% to 60% respond to a given SSRI trial.
- Options include switching, clomipramine and augmentation.
The Bottom Line
OCD Treatment Review is common and treatable, and careful care can make daily life feel more manageable.
Frequently Asked Questions
What is an OCD treatment review?
An OCD treatment review is a structured look at a plan that isn't working. It checks the diagnosis and whether medication trials were adequate in dose and length. It asks whether ERP was true exposure therapy done consistently. It looks for blockers like alcohol, benzodiazepines or accommodation. The goal is a clear next step.
How do I know if my OCD medication trial was adequate?
The International OCD Foundation notes an adequate SSRI trial for OCD requires 8 to 12 weeks. At least six of those weeks should be at moderate to high doses. Trials are often judged too early or at too low a dose. Consistent use matters too. A review checks each past trial against this standard.
What if I never had real ERP?
Many people have had therapy that didn't target OCD directly. True ERP uses a structured exposure hierarchy and deliberate resistance of rituals. It's practiced regularly between sessions. The International OCD Foundation describes it as first-line therapy. Starting or intensifying ERP is often a powerful next step.
What are the options after two SSRIs don't work?
The International OCD Foundation lists switching to clomipramine, augmenting with a second medication or switching to a second-line option. Low-dose antipsychotic augmentation is the most evidence-based augmentation strategy. It helps about one-third of SSRI non-responders. Intensifying ERP remains important. Your prescriber will explain the choices.
Is it okay to get a second opinion for OCD?
Yes, a second opinion is reasonable if you feel stuck. A fresh perspective can clarify the diagnosis or suggest new options. Bring records of past medications, doses and Y-BOCS scores. Most clinicians welcome coordinated care. It's your right to seek another view. An evaluation can clarify what's happening and which options fit.
Can an OCD treatment review happen by video in New York?
Yes, OCD treatment reviews happen by secure video anywhere in New York. You need to be physically in New York during each visit. Records and scores can be reviewed together. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office. Self-pay fees are listed on the Good Faith Estimate page.
Where to go from here
- Right now, if you're not safe
- Call or text 988, or call 911.
- If you'd like an evaluation
- See how scheduling and telehealth work on the new patient page.
- If you want to keep reading
- Return to our guide to OCD care in New York for more guides. For more help preparing and finding care, see NIMH’s tips for talking with your health care provider and FindTreatment.gov.
How We Reviewed This Page
Written by Steven Lockhart of Health Marketing Group and clinically reviewed by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist. Clinical information comes from the sources listed below, and the page is reviewed every 180 days or when guidance changes.
What’s new: September 29, 2026. Page published.
References
- International OCD Foundation. Understanding Medication for OCD. https://iocdf.org/about-ocd/ocd-treatment-guide/understanding-medication/
- International OCD Foundation. What is OCD? https://iocdf.org/about-ocd/
- 988 Suicide & Crisis Lifeline. https://988lifeline.org/
- Tips for talking with your health care provider. https://www.nimh.nih.gov/health/publications/tips-for-talking-with-your-health-care-provider
- FindTreatment.gov. https://findtreatment.gov/